Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia

    NEXT STORY
    Valneva Reports H1 Results Marked by Major Corporate Achievements and Strong Cash Position
    PREV STORY
    ORIC Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Hua Medicine’s Pivotal Phase III Monotherapy Trial of Dorzagliatin, a Dual-Acting Glucokinase Modulator, Achieves Primary Efficacy Endpoint in Patients with Type 2 Diabetes

    author_avatar
    NASDAQ Market News

    Diet Doc’s Specialized Diet Plans Instrumental in Helping Pre-Diabetic Patients Prevent Diabetes by Stabilizing Blood Sugar Levels Through Healthy, Safe and Fast Weight Loss

    DALLAS, April 18, 2016 (GLOBE NEWSWIRE) -- Scores of Americans are diagnosed with diabetes, ...

    author_avatar
    NASDAQ Market News

    BeyondSpring to Host Quarterly Operational Update Conference Call on August 21, 2017

    NEW YORK, Aug. 14, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical ...

    author_avatar
    NASDAQ Market News